Page 3 - Karim Dabbagh News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article BRISBANE, Calif., Jan. 25, 2021 /PRNewswire/ Second Genome, a leader in microbiome science, today announced the appointment of Susannah Cantrell, PhD, to the position of chief business officer, and Preeti G. Lal, PhD, to the position of chief scientific officer. Susannah Cantrell, PhD, joined Second Genome as chief business officer in November 2020. Dr. Cantrell has over 20 years of industry experience across global pipeline strategy, sales, operations, marketing and new product commercialization. Her experience covers multiple therapeutic areas including cell therapy, oncology, inflammation, anti-infectives, cardiology, neurology, nephrology and endocrinology. She most recently served as EVP and chief commercial officer at Tricida and prior to that was vice president and head of global commercial strategy and marketing oncology at Gilead Sciences where she was instrumental in leading and building its oncology and inflammation business from

Genentech rocheSusannah cantrellPreetig lalAlladapt immunotherapeuticsKarim dabbaghGilead sciencesBombay universityUniversity of missouriWestminster collegeTumor biology at stanford universityUniversity of south carolinaSecond genomeScientific advisory boardRoche diagnosticsIncyte genomicsMedical university